The directive of the Immunity to Pulmonary Pathogens Section (IPPS) is to further our understanding of how virulent pulmonary pathogens, including Francisella tularensis, Bordetella pertussis and SARS-CoV-2 evade and inhibit protective immunity in the lung. Our overall goal is to utilize this information for development of novel therapeutics and vaccines directed against a variety of infectious diseases. Additionally, through comparative studies using other pulmonary pathogens we aim to gain a comprehensive understanding of regulation of innate and adaptive immune responses in the lungs with a special emphasis on metabolism.

From left to right: Tara Wehrly, Benji Schwarz, Lydia Roberts, Eric Bohrnsen, Monica Valtierra, Forrest Jessop, Katy Bosio
Catharine (Katy) Bosio, Ph.D.
Chief, Immunity to Pulmonary Pathogens Section
Contact: For contact information, search the NIH Enterprise Directory.
Education:
Ph.D., 1998, Colorado State University
B.Sc., 1993, Washington State University
Forrest Jessop, Ph.D.
Biologist
Contact: For contact information, search the NIH Enterprise Directory.

Lydia M. Roberts, Ph.D.
Staff Scientist
Contact: For contact information, search the NIH Enterprise Directory.

Benji Schwarz, Ph.D.
Biochemist
Contact: For contact information, search the NIH Enterprise Directory.

Tara Wehrly
Biologist
Contact: For contact information, search the NIH Enterprise Directory.
Former Research Group Members
Rebecca V. Anderson, Ph.D.
Amanda Griffin, Ph.D.
Timothy Bauler, Ph.D.
Joshua B. Alinger, MD/Ph.D.
Elliot Wyatt, BSc
Katrina Diaz, MD/Ph.D.
Kaitlin Stromberg, BSc
Ian Leighton, BSc
Jennifer Chase, MSc
Deborah Crane, MSc
Robin Ireland, MSc